| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000228679.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016515186 |
Resistant |
| ENSG00000228679.1 |
Ponatinib |
Brain lower grade glioma |
0.015606761 |
Resistant |
| ENSG00000228679.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.015763582 |
Sensitive |
| ENSG00000228679.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.017428223 |
Sensitive |
